Smith & Nephew Reorganization May Foreshadow Imminent Zimmer Purchase
This article was originally published in The Gray Sheet
Executive SummarySmith & Nephew's recently announced corporate restructuring plan portends a possible acquisition of Bristol Myers Squibb's $1.8 bil. Medical Devices Group, which includes the Zimmer orthopedics and Convatec wound management businesses.
You may also be interested in...
Novartis’s cancer drug has now been filed for multiple sclerosis in the US, armed with a priority review, and in Europe.